0001193125-24-025307.txt : 20240206 0001193125-24-025307.hdr.sgml : 20240206 20240206163029 ACCESSION NUMBER: 0001193125-24-025307 CONFORMED SUBMISSION TYPE: DEFA14A PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20240206 DATE AS OF CHANGE: 20240206 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NexImmune, Inc. CENTRAL INDEX KEY: 0001538210 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DEFA14A SEC ACT: 1934 Act SEC FILE NUMBER: 001-40045 FILM NUMBER: 24600714 BUSINESS ADDRESS: STREET 1: 9119 GAITHER ROAD CITY: GAITHERSBURG STATE: MD ZIP: 20878 BUSINESS PHONE: 301-825-9810 MAIL ADDRESS: STREET 1: 9119 GAITHER ROAD CITY: GAITHERSBURG STATE: MD ZIP: 20878 DEFA14A 1 d752615ddefa14a.htm DEFA14A DEFA14A

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of

the Securities Exchange Act of 1934

(Amendment No. )

 

 

Filed by the Registrant ☒

Filed by a party other than the Registrant ☐

Check the appropriate box:

 

Preliminary Proxy Statement

 

Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

 

Definitive Proxy Statement

 

Definitive Additional Materials

 

Soliciting Material under §240.14a-12

NexImmune, Inc.

(Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check all boxes that apply):

 

No fee required

 

Fee paid previously with preliminary materials

 

Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

 

 

 


LOGO

9119 Gaither Road

Gaithersburg, MD 20877

February 6, 2024

NOTICE OF POSTPONEMENT OF

SPECIAL MEETING OF STOCKHOLDERS

As disclosed in a Form 8-K filed by NexImmune, Inc. (the “Company”) on February 5, 2024, the Board of Directors of the Company has determined to postpone the Company’s Special Meeting of Stockholders for the purpose of approving the liquidation and dissolution of the Company and the Plan of Liquidation and Dissolution (the “Special Meeting”), which was previously scheduled to reconvene on Wednesday, February 7, 2024 at 10:00 a.m., Eastern Time in a virtual format, while continuing to pursue alternatives intended to maximize the value of the business and its assets. Subject to the outcome of the Company’s pursuit of alternatives to maximize the value of the business and its assets, the Company may call a new Special Meeting of the stockholders to seek approval of the plan of dissolution, set a new record date for the determination of stockholders of the Company entitled to vote at the postponed Special Meeting, and file proxy materials relating to the postponed Special Meeting with the Securities and Exchange Commission. The new proxy materials and proxy card would be distributed to the stockholders by the Company in advance of the new meeting date.

GRAPHIC 2 g752615g0206201415204.jpg GRAPHIC begin 644 g752615g0206201415204.jpg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end